FdaApplication
BLA 761349
Identifiers
- fda_app_no: BLA761349
Properties
| Property | Value |
|---|---|
| applicant_name | Novartis Pharmaceuticals Corporation |
| application_type | BLA |
| approval_date | 2023-10-06 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| COSENTYX | SECUKINUMAB | 125MG/5ML | Injection |
1 product